Zydus Lifesciences Limited — Tramadol Exporter Profile
Indian Pharmaceutical Exporter · #9 for Tramadol · $5.5M export value · DGFT Verified
Zydus Lifesciences Limited is the #9 Indian exporter of Tramadol with $5.5M in export value and 208 verified shipments. Zydus Lifesciences Limited holds a 1.4% market share in Tramadol exports across 13 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Tramadol Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Tramadol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $1.9M | 79 | 40.9% |
| FRANCE | $778.2K | 44 | 17.0% |
| UGANDA | $516.5K | 13 | 11.3% |
| SPAIN | $494.6K | 24 | 10.8% |
| KENYA | $321.3K | 13 | 7.0% |
| MAURITIUS | $257.8K | 11 | 5.6% |
| BRAZIL | $121.3K | 5 | 2.6% |
| MEXICO | $114.2K | 5 | 2.5% |
| TANZANIA | $50.8K | 7 | 1.1% |
| THAILAND | $32.4K | 3 | 0.7% |
Zydus Lifesciences Limited exports Tramadol to 13 countries. The largest destination is SOUTH AFRICA accounting for 40.9% of Zydus Lifesciences Limited's Tramadol shipments, followed by FRANCE (17.0%) and UGANDA (11.3%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tramadol from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZYDUS HEALTHCARE SA (PTY) LTD | SOUTH AFRICA | $1.3M | 58 |
| ZYDUS HEALTHCARE SA (PTY) LTD. | SOUTH AFRICA | $349.5K | 12 |
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $331.0K | 15 |
| FTM (MAURITIUS) LTD. | MAURITIUS | $238.6K | 10 |
| ABACUS PHARMA (AFRICA) LTD | KENYA | $203.7K | 8 |
| DHL GLOBAL FORWARDING SPAIN | SPAIN | $197.8K | 6 |
| ZYDUS FRANCE | FRANCE | $196.9K | 6 |
| ABACUS PHARMA AFRICA LTD | KENYA | $174.5K | 5 |
| ABACUS PHARMA (AFRICA) LIMITED | UGANDA | $168.5K | 5 |
| ZYDUS HEALTHCARE SA PTY LTD | SOUTH AFRICA | $161.1K | 5 |
Zydus Lifesciences Limited supplies Tramadol to 32 buyers globally. The largest buyer is ZYDUS HEALTHCARE SA (PTY) LTD (SOUTH AFRICA), followed by ZYDUS HEALTHCARE SA (PTY) LTD. (SOUTH AFRICA) and CENTRE SPECIALITES PHARMACEUTIQUES (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tramadol Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $67.2M worth of Tramadol through 3,928 shipments from 249 suppliers to 103 countries, serving 789 buyers globally. Zydus Lifesciences Limited contributes $5.5M to this total, accounting for 1.4% of India's Tramadol exports. Zydus Lifesciences Limited ships Tramadol to 13 countries through 32 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Tramadol Exports?
Zydus Lifesciences Limited's average Tramadol shipment value is $26.5K per consignment, based on 208 shipments totaling $5.5M. The largest destination is SOUTH AFRICA (40.9% of Zydus Lifesciences Limited's Tramadol exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Tramadol Exporters?
Zydus Lifesciences Limited ranks #9 among 249 Indian Tramadol exporters with a 1.4% market share. The top 3 exporters are RUBICON RESEARCH PRIVATE LIMITED ($11.4M), UNICHEM LABORATORIES LIMITED ($10.3M), MEDREICH LIMITED ($8.2M). Zydus Lifesciences Limited processed 208 shipments to 13 destination countries.
What Tramadol Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TRAP 37.5MG/325MG TABLETS (TRAMADOL HYDR | $187.9K | 5 |
| TRAMADOL PARAC COMBIX 37 5 325MG 60 COMP B No G500419 MFG DT 02 2025 EXP DT 01 2028 Quantity 32603 000 B No G500420 M | $150.0K | 3 |
| TRAMAZAC INJECTION 100MG/2ML (TRAMADOL H | $147.4K | 4 |
| TRAMAZAC CAP 50MG 10X10 (TRAMADOL HYDROC | $136.6K | 4 |
| TRAMADOL TEVA ER TABS 100 MG TABLETS (TRAMADOL HYDROCHLORIDE) (EXPORT AUTHORIZATION NO. : P-EXP-11236/2024 DATE - 12/03/ | $107.6K | 3 |
| TRAM XL 100 TAB ( TRAMADOL HCL) PACK OF10 X 10 | $100.0K | 2 |
| TRAMAZAC INJECTION 2ML 5X2ML(TRAMADOL 10 | $98.0K | 4 |
| TRAMAZAC INJECTION 2ML 5X2ML (TRAMADOL 1 | $94.6K | 2 |
| TRAP 37.5MG/325MG TABLETS (TRAMADOL HYDROCHLORIDE + PARACETAMOL) 10 X 10 | $91.6K | 2 |
| TRAMAZAC CAPSULES 50MG (TRAMADOL HYDROCH | $70.2K | 4 |
Zydus Lifesciences Limited exports 133 distinct Tramadol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TRAP 37.5MG/325MG TABLETS (TRAMADOL HYDR with 5 shipments worth $187.9K.
Regulatory Requirements: Exporting Tramadol to Key Markets
What Zydus Lifesciences Limited must comply with to export Tramadol to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Lifesciences Limited Compare to Nearest Tramadol Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MEDREICH LIMITED | $8.2M | 229 | 9 | $35.8K |
| 8 | GRACURE PHARMACEUTICALS LIMITED | $5.6M | 124 | 4 | $44.8K |
| 9 | ZYDUS LIFESCIENCES LIMITED ★ | $5.5M | 208 | 13 | $26.5K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $5.1M | 102 | 4 | $50.0K |
| 10 | INDOCO REMEDIES LIMITED | $4.3M | 87 | 7 | $50.0K |
Zydus Lifesciences Limited ranks #9 among 249 Indian Tramadol exporters. Average shipment value of $26.5K compared to the market average of $270.0K. The closest competitors by value are MEDREICH LIMITED and GRACURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Tramadol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 463 | 11.8% |
| SAHAR AIR | 405 | 10.3% |
| JNPT/ NHAVA SHEVA SEA | 289 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 264 | 6.7% |
| JNPT | 199 | 5.1% |
| MUNDRA SEA | 150 | 3.8% |
| VIZAG SEA | 108 | 2.7% |
| BANGALORE ICD | 106 | 2.7% |
What Other Analgesics & Antipyretics Products Does Zydus Lifesciences Limited Export?
Zydus Lifesciences Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Tramadol Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Tramadol, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tramadol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tramadol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 208 individual customs records matching Zydus Lifesciences Limited exporting Tramadol, covering 133 formulations to 13 countries via 32 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 789+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tramadol Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Tramadol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Tramadol Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tramadol. For current shipment-level data, contact TransData Nexus.